The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis
Open accessAbstract
Summary Background The emergence and spread of high levels of HIV-1 drug resistance in resource-limited settings where combination antiretroviral treatment has been scaled up could compromise the effectiveness of national HIV treatment programmes. We aimed to estimate changes in the prevalence of HIV-1 drug resistance in treatment-naive individuals with HIV since initiation of rollout in resource-limited settings. Methods We did a systematic search for studies and conference abstracts published between January, 2001, and July, 2011, and included additional data from the WHO HIV drug resistance surveillance programme. We assessed the prevalence of drug-resistance mutations in untreated individuals with respect to time since rollout in a series of random-effects meta-regression models. Findings Study-level data were available for 26 102 patients from sub-Saharan Africa, Asia, and Latin America. We recorded no difference between chronic and recent infection on the prevalence of one or more drug-resistance mutations for any region. East Africa had the highest estimated rate of increase at 29% per year (95% CI 15 to 45; p=0·0001) since rollout, with an estimated prevalence of HIV-1 drug resistance at 8 years after rollout of 7·4% (4·3 to 12·7). We recorded an annual increase of 14% (0% to 29%; p=0·054) in southern Africa and a non-significant increase of 3% (–0·9 to 16; p=0·618) in west and central Africa. There was no change in resistance over time in Latin America, and because of much country-level heterogeneity the meta-regression analysis was not appropriate for Asia. With respect to class of antiretroviral, there were substantial increases in resistance to non-nucleoside reverse transcriptase inhibitors (NNRTI) in east Africa (36% per year [21 to 52]; p<0·0001) and southern Africa (23% per year [7 to 42]; p=0·0049). No increase was noted for the other drug classes in any region. Interpretation Our findings suggest a significant increase in prevalence of drug resistance over time since antiretroviral rollout in regions of sub-Saharan Africa; this rise is driven by NNRTI resistance in studies from east and southern Africa. The findings are of concern and draw attention to the need for enhanced surveillance and drug-resistance prevention efforts by national HIV treatment programmes. Nevertheless, estimated levels, although increasing, are not unexpected in view of the large expansion of antiretroviral treatment coverage seen in low-income and middle-income countries—no changes in antiretroviral treatment guidelines are warranted at the moment. Funding Bill & Melinda Gates Foundation and the European Community's Seventh Framework Programme
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kendall's Advanced Theory of Statistics.
AA, Stuart, A., & Ord, K. (1995) · Journal of the American Statistical Association · doi:10.2307/2291187 · Cited by 2,619
Kendall's Advanced Theory of Statistics.
Kemp, A. W., Stuart, A., & Ord, J. K. (1994) · The Statistician · doi:10.2307/2348968 · Cited by 1,349
Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update
Bennett, D. E., Camacho, R. J., Otelea, D., Kuritzkes, D. R., Fleury, H., Kiuchi, M., Heneine, W., Kantor, R., Jordan, M. R., Schapiro, J. M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004724 · Cited by 938
Self-citationStijnen, T., Hamza, T. H., & Özdemir, P. (2010) · Statistics in Medicine · doi:10.1002/sim.4040 · Cited by 757
The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings
Gilks, C. F., Crowley, S., Ekpini, R., Gove, S., Perriens, J., Souteyrand, Y., Sutherland, D., Vitoria, M., Guerma, T., & De Cock, K. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69158-7 · Cited by 689
Barth, R. E., van der Loeff, M. F. S., Schuurman, R., Hoepelman, A. I., & Wensing, A. M. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70328-7 · Cited by 310
Bennett, D. E., Myatt, M., Bertagnolio, S., Sutherland, D., & Gilks, C. F. (2008) · Antiviral Therapy · doi:10.1177/135965350801302s04 · Cited by 291
Self-citationHosseinipour, M. C., van Oosterhout, J. J., Weigel, R., Phiri, S., Kamwendo, D., Parkin, N., Fiscus, S. A., Nelson, J. A., Eron, J. J., & Kumwenda, J. (2009) · AIDS · doi:10.1097/qad.0b013e32832ac34e · Cited by 288
Hamers, R. L., Wallis, C. L., Kityo, C., Siwale, M., Mandaliya, K., Conradie, F., Botes, M. E., Wellington, M., Osibogun, A., Sigaloff, K. C. E., et al. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70149-9 · Cited by 287
Self-citationConfidence Intervals vs Bayesian Intervals
Jaynes, E. T., & Kempthorne, O. (1976) · Foundations of Probability Theory, Statistical Inference, and Statistical Theories of Science · doi:10.1007/978-94-010-1436-6_6 · Cited by 285
Cited by
Gupta, R. K., Gregson, J., Parkin, N., Haile-Selassie, H., Tanuri, A., Andrade Forero, L., Kaleebu, P., Watera, C., Aghokeng, A., Mutenda, N., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30702-8 · Cited by 414
Self-citationDefeating AIDS—advancing global health
Piot, P., Abdool Karim, S. S., Hecht, R., Legido-Quigley, H., Buse, K., Stover, J., Resch, S., Ryckman, T., Møgedal, S., Dybul, M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60658-4 · Cited by 293
Brenner, B. G., Oliveira, M., Ibanescu, R.-I., Routy, J.-P., & Thomas, R. (2023) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkad184 · Cited by 18
Metadata
- Authors
- Gupta, R. K., Jordan, M. R., Sultan, B. J., Hill, A., Davis, D. H., Gregson, J., Sawyer, A. W., Hamers, R. L., Ndembi, N., Pillay, D., & Bertagnolio, S.
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2012-10
- Volume
- 380
- Issue
- 9849
- Pages
- 1250-1258
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2170463669
- Cited by
- 364
- References
- 25
- FWCI
- 29.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis. https://app.cochat.ai/papers/10.1016/s0140-6736(12)61038-1
- The paper
- Gupta, R. K., Jordan, M. R., Sultan, B. J., Hill, A., Davis, D. H., Gregson, J., Sawyer, A. W., Hamers, R. L., Ndembi, N., Pillay, D., & Bertagnolio, S. (2012). Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis. The Lancet. https://doi.org/10.1016/s0140-6736(12)61038-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.